Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juniperus californica pollen
- Development stage
- Unknown
- Lead developer
- Allermed Laboratories
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intradermal, Percutaneous, Subcutaneous, Sublingual
01
Overview
Juniperus californica pollen (also known as California Juniper pollen) is an allergenic extract indicated for both diagnostic skin testing and subcutaneous immunotherapy. [8] It is used to identify and treat individuals with allergic conditions caused by sensitivity to pollen from the California Juniper tree. The product is an injectable solution containing pollen extract from *Juniperus californica* in a phenol-preserved sodium bicarbonate buffer. As an immunomodulatory agent, it works by gradually desensitizing the immune system to the specific allergens, thereby reducing the severity of allergic reactions upon subsequent exposure. [5] Due to the risk of severe systemic reactions, including anaphylaxis, it is intended for administration by physicians experienced in allergen immunotherapy. [8]
- Other names
- California Juniper pollenCalifornia Juniper pollen extract
02
Targets
BCR (Immunoglobulin G B Cell Receptor)
Beyond the preview
Go deeper on Juniperus californica pollen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Juniperus californica pollen.